Navigation Links
Preventing and improving treatment of Alzheimer's disease

This news release is available in French.

On September 19, INRS director general Daniel Coderre and INRSInstitut Armand-Frappier Centre director Charles M. Dozois announced the creation of the Louise and Andr Charron Research Chair in Alzheimer's Disease. Funded by a generous gift from the Louise and Andr Charron family to the Armand-Frappier Foundation of INRS University, the chair's research program will focus on prevention, early detection, and improved treatment of the disease, which is a growing problem in North America and around the world. Professor Charles Ramassamy of the INRSInstitut Armand-Frappier Centre is the first chairholder.

Over 35 million people worldwide have Alzheimer's disease, including more than 450,000 in Canada alone. Based on current data, if no action is taken, 65 million people around the world will have the disease by 2030, and that number will grow to 115 million by 2050. By the time Alzheimer's symptoms appear, 80% of the neurons involved in cognitive processing have degenerated and considerable damage has already been done. When the disease is diagnosed, the goal of treatment is to alleviate symptoms rather than to control the disease.

"In light of the alarming number of families affected by Alzheimer's disease, there is an urgent need to get to the root of this scourge. In our view, fundamental research holds the most promise for eradicating the disease," said Andr B. Charron, a member of the donor family.

Toward better patient care

For Professor Ramassamy, developing early detection tools for Alzheimer's disease is the first step in providing better patient care and improving patient quality of life. "We are looking for biomarkers that can not only show that neurodegeneration has begun in a patient, but also provide more insight into the stage of the disease. From there, clinical teams may be able to slow the progression of the disease or treat it, with the hope that patients will be able to maintain their independence for as long as possible."

What's more, current pharmacological treatments for Alzheimer's disease often have serious side effects that can interrupt treatment and negatively affect patient quality of life. The chair's research program will tackle this problem by identifying less toxic therapeutic moleculesmainly plant- and food-derived polyphenolsand harnessing nanoparticles to deliver them to the brain more efficiently, resulting in smaller doses.

"Under the direction of Professor Charles Ramassamy, this new research chair will not only develop innovative strategies for preventing and fighting Alzheimer's disease, it will also bring hope to current and future patients and their families. This generous gift from the Louise and Andr Charron family is a testament to our researchers' expertise and will help advance critical understanding of the disease in order to improve people's health and well-being," explained INRS director general Daniel Coderre.


Contact: Stephanie Thibault
450-687-5010 x8865

Related medicine news :

1. Berkeley, CA Periodontist Dr. Keith Chertok is Preventing Gum Disease during Pregnancy by Offering Laser Gum Surgery to Reduce Low Birth Weight Risks
2. Dr. Bonnie Weil Provides Tips on Preventing the Loneliness of the Empty Nest
3. Brandith Irwin, MD, Answers New Blog Question on Her Website About Preventing Eye Wrinkles at Ages 30 to 40
4. Preventing Simple Surgical Mistakes That Can Have a Lasting Impact
5. Preventing eggs death from chemotherapy
6. hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announces Uncomplicated New Diet Plans for Men to Aid in Preventing Certain Cancers Due to Excess Weight
7. Dr. Robin Fleck Shares Tips on Preventing Sunburn
8. Aspirin Equals Pricier Blood Thinner for Preventing Clots: Study
9. Likelihood of Spousal HPV Oral Infection, Predictors of Melanoma and Throat Cancer, Preventing Cancer Readmissions
10. Spousal oral HPV, predictors of melanoma and throat cancer, preventing cancer readmissions
11. As Summer Approaches, Experts Offer Tips on Preventing Skin Cancer
Post Your Comments:
(Date:11/27/2015)... ... November 27, 2015 , ... Dr. Thomas Dunlap and ... and Dr. Tucker Bierbaum with Emergency Medicine at St., Joseph Health System’s Santa ... and Sepsis conditions present in similar ways and require time-critical intervention to avoid large ...
(Date:11/26/2015)... ON (PRWEB) , ... November 26, 2015 , ... ... of a real-time eReferral system for diagnostic imaging in the Waterloo region. Using ... BMD and Nuclear Medicine tests directly from their electronic medical record (EMR) without ...
(Date:11/26/2015)... Mass. (PRWEB) , ... November 26, 2015 , ... ... thorough second medical opinion process, participated in the 61st annual Employee Benefits Conference. ... Plans and took place Sunday, November 8th through Wednesday, November 11th, 2015. The ...
(Date:11/25/2015)... ... 25, 2015 , ... As part of a global movement ... volunteers together who want to combine talents and resources to help create sustainable ... process. The non-profit launched its first major fundraiser on November 6, 2015 at ...
(Date:11/25/2015)... ... November 25, 2015 , ... Dr. John Pierce, Medical Director at the ... loss treatment with the Capillus272™ Pro laser therapy cap. FDA cleared for safety and ... hair, without the need for surgery, prescription pills, or topical foams. , “Capillus272™ ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... , Nov. 25, 2015  The American ... and Gynecologists (ACOG), and the March of Dimes ... Protecting Our Infants Act of 2015 ... number of newborns born exposed to drugs, such ... the bill,s introduction, all three organizations have worked ...
(Date:11/25/2015)... On Tuesday, November 24, 2015, the ... Wright Medical Technology, Inc. for product liability and ... implant device, awarded $11 million in favor of ... and three days of deliberations, the jury found ... designed and unreasonably dangerous, and that Wright Medical ...
(Date:11/25/2015)... AVIV, Israel , November 25, 2015 ... (NASDAQ: KTOV ) (TASE: KTOV), a biopharmaceutical company ... simultaneous treatment of various clinical conditions, today announced the ... 3,158,900 American Depository Shares ( ADSs ), each representing ... purchase up to 3,158,900 ADSs. The ADSs and warrants ...
Breaking Medicine Technology: